Navigation Links
Depth of MedImmune's Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society


-- Eosinophils, Mast Cells and Neutrophils as Modulators of Immunity and


-- Poster Session: In Vitro Characterization of MEDI-563, a Humanized

Anti-IL-5Ralpha Monoclonal Antibody in Phase1 Clinical Trial,

publication page A602

-- Poster Session: MEDI-563, a Humanized Anti-Human IL-5R alpha Antibody

Binds to Lung Tissue Eosinophils in Asthmatic Patients, publication

page A602

-- Poster Session: A Monoclonal Anti-IL-5 Receptor (IL-5R) alpha

Antibody with Enhanced ADCC Selectively and Efficaciously Depletes

Tissue Eosinophils in IL-5 Transgenic Mice, publication page A603

The preceding presentations will occur on Tuesday, May 20 from 8:15 a.m. - 4:15 p.m., Metro Toronto Convention Centre, Area B.

-- Monocytes and Macrophages in Inflammation, Immunity and Injury (Poster

Session: Role for Alveolar Macrophages in Limiting Primary RSV

Immunopathology, publication page A623) - Tuesday, May 20 from 8:15

a.m. - 4:15 p.m., Metro Toronto Convention Centre, Area B.

About MedImmune

MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN) and is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland. MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience. For more information, visit MedImmune's website at

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Indexes
2. Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions
3. PARI Respiratorys LC PLUS & PRONEB Ultra Deliver Dey, L.P.s New COPD Therapy; Perforomist Launched Yesterday
4. Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement
5. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
6. Retired Supreme Court Justice Sandra Day OConnor and Former House Speaker Newt Gingrich Address Senate Special Committee on Aging, Calling for Urgent Action Against Alzheimers Disease
7. ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics
8. Vermillions Roundtable Teleconference Highlights Peripheral Artery Disease Diagnostic Program; Features Commentary from Vascular Medicine Expert
9. Novel Approach to Treat Alzheimers and Other Diseases Offered by Targeting Cell Membrane RAFTS
10. Liver Diseases: A Huge European Health Burden, But Some Trends are Positive
11. Sirion Therapeutics Preclinical Studies: Two New Potential Advances in Treatment of Retinal Diseases to be Presented at ARVO
Post Your Comments:
(Date:10/9/2015)... -- Pulmatrix, Inc., (NASDAQ: PULM ) will be webcasting the ... th Annual BIO Investor Forum on Tuesday, October ... --> th Annual BIO Investor Forum on ... EDT). --> Pulmatrix will be presenting at ... Thursday, October 15, 2015 at 8:30 am EDT. Additionally, the ...
(Date:10/8/2015)...  Sorrento Therapeutics, Inc. (NASDAQ:  SRNE; Sorrento), a ... and associated pain, announced today that Dr. Henry Ji, President ... the Aegis Capital Corporation 2015 Growth Conference in ... 2015 Growth ConferenceDate:Friday, October 9, 2015Time:10:00 to 10:30 ... Wynn in Las Vegas, NV , ...
(Date:10/8/2015)... .   ... Goldman Small Cap Research, a stock market research ... sectors, announced today that it has published a ... (OTCQB - PMCB), a publicly traded, clinical stage ... for cancer and diabetes. To view the sponsored ...
(Date:10/8/2015)... VANCOUVER , Oct. 8, 2015 /PRNewswire/ - RepliCel Life ... regenerative medicine company focused on the development of autologous ... licensing and partnering meetings taking place in the month ... Mesa – Partnering Forum RepliCel will be presenting ... Cell Meeting on the Mesa to be held October ...
Breaking Biology Technology:
... 3 Kendle (Nasdaq: KNDL ), a leading, ... participate in the upcoming Robert Baird 2009 Health Care Conference ... York in New York City. , , ... Kendle,s formal presentation will be given by Senior ...
... , , BETHESDA, Md., Sept. ... innovator in biotechnology for diabetes therapy, and a provider of ... pharmaceutical companies, today announced that Dr. Claire Kruger, Chief Executive ... corporate overview at the Rodman & Renshaw 11(th) Annual Healthcare ...
... , , NEW YORK, Sept. 3 ... catalogue. , , Proteomics: Technologies and Global ... , , REPORT HIGHLIGHTS ... is expected to increase from $6.7 billion in 2008 to an estimated ...
Cached Biology Technology:
(Date:10/9/2015)... , Oct. 09 2015 ... the addition of the "Samsung Galaxy ... report to their offering. --> ... of the "Samsung Galaxy S6 Fingerprint ... to their offering. --> Research ...
(Date:10/8/2015)... 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... announced today that it will report financial results ... Thursday, October 22, 2015, after the close of ... call for analysts and investors at 2:00 p.m. ... discuss forward-looking information. ). ...
(Date:10/8/2015)... 8. Oktober 2015 Die Track ... Unternehmen des Bereiches Tracking, hat heute bekannt ... Gefängnisbehörde Virginias (Department of Corrections – DOC) ... für alle Strafen geliefert werden, die der ... Präsident für den Amerikanischen Kontinent der Track ...
Breaking Biology News(10 mins):
... the brain by the hunger-signaling hormone ghrelin, researchers say. ... the pharmacologic control of cholesterol levels. The ... the University of Cincinnati (UC) endocrinology division, appears online ... Nature Neuroscience . "We have long thought ...
... With the rapid and continuous advances in biotechnology, scientists ... cell to unlock the secrets of its genetic material. However, ... remained a mystery. Now, researchers with the National Institutes of ... nucleus determines a cell,s behavior. They looked at mouse immune ...
... sources, oils, paints, and more from biomass as a raw ... obtained. Aware of this, engineer Mara Gonzlez looked for the ... suitable processing techniques and technologies for refining them. Her aim ... and thus substitute them for fossil fuels in the future. ...
Cached Biology News:
50 assays. Provides an easy system for rapid separation of cytosol and particulate fractions that are compatiable with downstream studies....
Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25....
Eliminate electrical interference from any analog signal, without filtering. Ideal for electrophysiology applications like EKG, EMG, and EEGs. Removes 50/60hz noise and harmonics caused by grounding ...
... For real-time or pre-programmed liquid ... electrochemistry, or general liquid-handling research ... millisecond accuracy. Run ... Microprocessor-based for accuracy and ...
Biology Products: